Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Mar 12, 2026
Why Is UiPath (PATH) Stock Down -10% Today?

Why Is UiPath (PATH) Stock Down -10% Today?

Key Takeaways

  • PATH shares fell approximately 10% in premarket trading on March 12, 2026, reversing the prior session's 6.82% gain, as investors digested Q4 fiscal 2026 earnings released after the close on March 11.
  • The primary catalyst for the selloff was disappointing FY2027 revenue guidance, which implies approximately 8–9% top-line growth — a notable deceleration from the 13% growth delivered in FY2026.
  • UiPath missed GAAP EPS estimates, reporting $0.19 per share versus the $0.26 consensus, a miss of approximately 27%, despite beating on revenue.
  • The dollar-based net retention rate held at 107%, signaling modest customer expansion and raising concerns about the pace of upsell within the existing enterprise base.
  • The broader software sector has faced multiple compression amid elevated interest rate expectations, amplifying valuation-sensitive reactions to slowing growth narratives.
  • Traders are now watching the Q1 FY2027 earnings cycle and whether AI-driven ARR can reaccelerate revenue growth expectations.

Opening Summary

UiPath, Inc. (PATH) is a New York-based enterprise automation software company and a global leader in robotic process automation (RPA) and agentic AI platforms, serving thousands of organizations worldwide. Shares dropped approximately 10% in premarket trading on March 12, 2026, from the prior session's closing price of $12.38, placing the stock near the $11.15 level. The prior regular-session close on March 11 was $12.38, which itself represented a nearly 7% intraday gain on earnings optimism — a gain that has now been entirely erased in the after-market reaction. The selloff was triggered by a mix of a GAAP EPS miss and, critically, fiscal 2027 guidance that fell short of investors' growth acceleration hopes.

Earnings Results: Beat on Revenue, Miss on the Bottom Line

UiPath reported Q4 fiscal 2026 revenue of $481.1 million, a 14% year-over-year increase that topped Wall Street's consensus estimate of approximately $464.9 million by more than $16 million.  On a Non-GAAP basis, EPS came in at $0.30, beating estimates of $0.25 by $0.05.  However, GAAP EPS of $0.19 fell materially short of the $0.26 consensus, a miss of roughly 27%, which drew scrutiny from investors focused on bottom-line accountability.  Full-year fiscal 2026 revenue totaled $1.611 billion — up 13% year-over-year — and the company achieved GAAP operating income of $57 million for the full year, its first-ever full-year GAAP profitability milestone.

Guidance Disappointment: The Core Catalyst

The dominant driver behind the post-earnings selloff was the FY2027 revenue outlook. Management guided full-year fiscal 2027 revenue to $1.754–$1.759 billion, implying approximately 8–9% growth compared to FY2026's $1.611 billion — a meaningful deceleration from the 13% growth rate just delivered.  For Q1 FY2027, the company guided revenue of $395–$400 million and non-GAAP operating income of approximately $80 million — broadly in line with, rather than ahead of, market consensus.  In a market that had priced in continued high-growth execution from an AI-leveraged automation platform, guidance that signals a transition to slower, more mature growth was read as a material disappointment. The lack of a clear "beat-and-raise" narrative on the top line effectively reset investor expectations downward.

ARR Growth and Customer Expansion Concerns

Annual Recurring Revenue (ARR) reached $1.853 billion at the end of Q4, up 11% year-over-year, consistent with the prior quarter's pace rather than showing any acceleration.  The dollar-based net retention rate of 107% — while positive — suggests limited expansion velocity from within the existing customer base, a metric that high-multiple software investors closely monitor.  The number of customers with ARR above $1 million grew from 317 to 357 year-over-year, demonstrating continued enterprise momentum, but the overall growth cadence fell short of the inflection point many investors were looking for.

Insider Activity and Sentiment Overhang

Adding to investor unease, CEO Daniel Dines and CFO Ashim Gupta have both recently sold shares, and the earnings release noted that the company repurchased 14 million shares at an average price of $12.11 between February 1 and March 10 — near current trading levels.  While the $500 million buyback authorization signals management's confidence in intrinsic value, CEO share sales alongside a guidance reset created a mixed sentiment environment, particularly for momentum-oriented investors.

Market Context and Trading Activity

The premarket decline follows a "sell the news" pattern that has become common in software earnings. PATH had rallied significantly in the days leading up to its March 11 results, gaining roughly 24.55% over the prior two weeks.  The stock's rapid ascent ahead of earnings left it vulnerable to a sharp pullback on any guidance miss or lack of a meaningful upside surprise. Volume in recent sessions has been significantly elevated relative to average daily volume, consistent with options-driven activity and speculative positioning ahead of the event. The broader enterprise software sector has also faced headwinds from macro uncertainty and interest rate sensitivity, providing little cushion for valuation-multiple compression in the face of decelerating growth guidance.

Trending AI Robots

For investors navigating volatile earnings-driven moves like PATH's, Tickeron's Trending AI Robots page offers a curated view of the highest-performing AI trading bots currently active on the platform. Tickeron operates hundreds of AI-powered bots covering thousands of tickers, but only those delivering the strongest results under prevailing market conditions are featured in this Trending section. Each bot is distinct in strategy, timeframe, performance metrics, and the symbols it trades — ranging from short-term momentum plays to swing and position strategies. Whether you are looking to act on a sharp premarket move or position for a post-earnings recovery, exploring the Trending AI Robots section may surface tools aligned with your trading style and risk tolerance.

What Comes Next for PATH

The next major milestone for PATH investors will be the Q1 FY2027 earnings report, where the market will assess whether the guided revenue range of $395–$400 million is achieved or exceeded.  Analysts will focus on whether AI-driven ARR — which contributed $200 million in the most recent period — can continue expanding and whether the dollar-based net retention rate shows any recovery above its current 107% level.  With a consensus analyst rating of "Hold" and a range of price targets from the mid-teens to $19, the path forward hinges largely on UiPath's ability to demonstrate that its Agentic Automation strategy can reignite top-line growth beyond the currently guided 8% trajectory.  Macro headwinds, competitive dynamics in the AI automation space, and broader enterprise IT spending trends will also remain key variables for PATH shareholders to monitor in the months ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: PATH

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


PATH in downward trend: price dove below 50-day moving average on September 15, 2026

PATH moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend. In 38 of 46 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PATH as a result. In 62 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The 10-day moving average for PATH crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 72%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PATH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

The Aroon Indicator for PATH entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PATH's RSI Oscillator exited the oversold zone, 22 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 58 of 68 cases where PATH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

The Moving Average Convergence Divergence (MACD) for PATH just turned positive on October 05, 2026. Looking at past instances where PATH's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.

Following a +8.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where PATH advanced for three days, in 238 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

PATH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.261) is normal, around the industry mean (18.522). P/E Ratio (18.194) is within average values for comparable stocks, (158.311). Projected Growth (PEG Ratio) (0.447) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (4.248) is also within normal values, averaging (104.490).

The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. PATH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PATH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Twilio (NYSE:TWLO), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), Okta (NASDAQ:OKTA), Zscaler (NASDAQ:ZS), MongoDB (NASDAQ:MDB).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.56B. The market cap for tickers in the group ranges from 48.8K to 3.78T. MSFT holds the highest valuation in this group at 3.78T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 3%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 27%. BIRD experienced the highest price growth at 46%, while VERI experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -1%. For the same stocks of the Industry, the average monthly volume growth was -27% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 70
Price Growth Rating: 57
SMR Rating: 78
Profit Risk Rating: 91
Seasonality Score: 3 (-100 ... +100)
View a ticker or compare two or three
PATH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ComputerCommunications

Industry
N/A
Address
One Vanderbilt Avenue
Phone
+1 844 432-0455
Employees
3981
Web
https://www.uipath.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
Toyota Motor Corporation (TM) stands as the world's largest automaker by volume, designing, manufacturing, and selling a wide range of vehicles—from sedans and trucks to SUVs and electrified models like hybrids—under brands including Toyota, Lexus, and Daihatsu. The company's business model centers on a robust global supply chain, vertical integration in components like engines and transmissions, and a multi-pathway approach that prioritizes hybrids alongside EVs and hydrogen technology. In the highly competitive automotive sector, Toyota maintains a strong position, particularly with its dominant hybrid market share, though it faces mounting pressure from EV frontrunners such as BYD in China and Tesla worldwide. From what I see, these core strengths explain much of the recent stock action: the resilience from hybrids offers some stability, but the slower EV rollout and heavy China exposure heighten sales volatility in a shifting market.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Sable Offshore Corp. (SOC) shares fell 7.40% in the most recent completed session, closing at $16.52 versus a prior close of $17.84. The pullback followed a volatile stretch in which SOC traded between $15.76 and $19.21 over just two sessions, reflecting profit‑taking after a strong run in March.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.